相关实验视频

Updated: Aug 2, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

IKZF3多态性导致儿童急性淋巴细胞白血病的风险增加

Xu Yang^1,2, Lihua Yang³, Annie Luo⁴

¹Department of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

|November 29, 2023

概括

在IKZF3中单核酸多态 (SNP) 与儿童急性淋巴细胞白血病 (ALL) 风险增加有关. 这些IKZF3SNP可能会影响基因表达,表明它们作为儿科ALL生物标志物的潜力.

科学领域:

遗传学遗传学是一个
儿科瘤学儿科瘤学
分子生物学分子生物学

背景情况:

急性淋巴细胞白血病 (ALL) 是最常见的儿童癌症.
转录因子IKZF3参与白血病,但其单核酸多态 (SNP) 的作用尚不清楚.
这项研究调查了IKZF3SNP与儿童ALL风险之间的关联.

研究的目的:

调查IKZF3单核酸多态 (SNP) 与儿童急性淋巴细胞白血病 (ALL) 风险的相关性.
探索已识别的SNP对IKZF3基因调节的潜在功能影响.

主要方法:

一个病例控制研究在692个ALL病例和926个对照中对6个IKZF3SNP进行了基因型鉴定.
通过使用几率比率 (ORs),95%置信区间 (CI) 和假阳性报告概率 (FPRP) 分析来分析关联.
进行了in silico功能分析,以评估SNP对IKZF3调节的影响.

主要成果:

两个SNP,rs9635726和rs2060941,与ALL风险的增加有显著联系.
FPRP分析证实了rs9635726和rs2060941与ALL的显著关联.
功能分析表明,这些SNP可能通过破坏与调节蛋白结合来抑制IKZF3转录.

结论:

IKZF3多态性与儿童ALL的易感性增加有关.
这些多态可能会通过改变蛋白质结合来影响IKZF3的表达.
建议IKZF3 SNPs作为儿科ALL的潜在生物标志物.

关键词:

在IKAROS家族的指3 (IKZF3) 中.急性淋巴细胞白血病 (ALL)孩子们的孩子们的孩子们的孩子们.单核酸多态 (单核酸多态,简称SNP)易感性易感性易感性

更多相关视频

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...